| Unichem Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 506690 |
NSE Symbol : UNICHEMLAB |
P/E(TTM) : - |
|
ISIN Demat : INE351A01035 |
Div & Yield% : - |
EPS(TTM) : 0.37 |
|
Book Value(₹) : 325.91 |
Market Cap(₹Cr) : 4,511.25 |
Face Value(₹) : 2.00 |
| Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | |
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Equity Share Capital | 14.08 | 14.08 | 14.08 | 14.08 | 14.08 |
| Reserves | 2,280.54 | 2,370.19 | 2,657.96 | 2,683.25 | 2,633.10 |
| Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Shareholders Funds | 2,294.62 | 2,384.27 | 2,672.04 | 2,697.33 | 2,647.18 |
| Secured Loans | 63.89 | 101.68 | 126.10 | 0.00 | 15.21 |
| Unsecured Loans | 6.41 | 6.58 | 5.98 | 1.48 | 1.50 |
| Total Debt | 70.30 | 108.26 | 132.08 | 1.48 | 16.71 |
| Other Liabilities | 36.67 | 43.00 | 44.65 | 35.11 | 28.20 |
| Total Liabilities | 2,401.59 | 2,535.53 | 2,848.77 | 2,733.92 | 2,692.09 |
| APPLICATION OF FUNDS : | |||||
| Gross Block | 1,718.31 | 1,690.90 | 1,323.61 | 1,128.16 | 1,039.21 |
| Less: Accumulated Depreciation | 553.37 | 454.95 | 360.49 | 278.40 | 210.68 |
| Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Block | 1,164.94 | 1,235.95 | 963.12 | 849.76 | 828.53 |
| Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Work in Progress | 122.36 | 147.82 | 494.18 | 567.73 | 330.84 |
| Investments | 44.07 | 40.51 | 389.80 | 520.42 | 668.28 |
| Current Assets, Loans & Advances | |||||
| Inventories | 500.53 | 480.19 | 460.69 | 386.12 | 315.57 |
| Sundry Debtors | 558.42 | 472.08 | 380.84 | 360.48 | 323.10 |
| Cash and Bank Balance | 129.06 | 157.28 | 99.03 | 57.59 | 205.37 |
| Loans and Advances | 216.79 | 181.68 | 169.81 | 264.75 | 241.57 |
| Total Current Assets | 1,404.80 | 1,291.23 | 1,110.38 | 1,068.94 | 1,085.61 |
| Less : Current Liabilities and Provisions | |||||
| Current Liabilities | 326.25 | 338.61 | 257.21 | 356.60 | 323.22 |
| Provisions | 135.85 | 12.01 | 16.09 | 14.83 | 9.81 |
| Total CL & Provisions | 462.10 | 350.61 | 273.30 | 371.43 | 333.03 |
| Net Current Assets | 942.69 | 940.61 | 837.08 | 697.51 | 752.58 |
| Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Assets | 0.00 | 0.00 | 0.00 | 62.63 | 90.26 |
| Deferred Tax Liability | 0.00 | 0.00 | 0.00 | 76.34 | 90.26 |
| Net Deferred Tax | 0.00 | 0.00 | 0.00 | -13.71 | 0.00 |
| Other Assets | 127.53 | 170.63 | 164.61 | 112.21 | 111.88 |
| Total Assets | 2,401.59 | 2,535.51 | 2,848.79 | 2,733.92 | 2,692.11 |
| Contingent Liabilities | 125.91 | 363.69 | 170.79 | 177.17 | 211.66 |